Roger Jeffs - Director, Sangamo Therapeutics, Inc

As of September 7, 2018


Roger Jeffs Net Worth

  • Net worth is estimated to be at least $184.24M
  • Owns at least 9,908 units of Sangamo Therapeutics, Inc stock

Roger Jeffs Trading

  • Largest purchase of shares was 7,408 units , worth over $100.49K on September 7, 2018
  • In total has made about 3 transactions over a year
  • Usually trades in June, with the busiest year in 2018
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Sangamo Therapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Alexander D. Macrae 2020 $681,797 $ $1,147,500 $1,488,746 $511,348 $5,639 $3,835,030
Alexander D. Macrae 2019 $661,939 $ $571,148 $2,274,230 $436,880 $42,358 $3,986,555
Alexander D. Macrae 2018 $636,480 $ $631,575 $2,410,657 $420,077 $5,639 $4,104,428
Sung H. Lee 2020 $438,262 $ $340,000 $443,316 $215,000 $5,639 $1,442,217
Sung H. Lee 2019 $72,500 $200,000 $452,813 $1,757,679 $47,415 $273 $2,530,680
Gary H. Loeb 2020 $406,000 $ $340,000 $441,110 $200,564 $5,639 $1,393,313
Gary H. Loeb 2019 $166,667 $ $ $1,788,475 $87,200 $683 $2,043,025
D. Mark McClung 2020 $276,667 $150,000 $916,000 $1,187,220 $136,245 $5,093 $2,671,225
R. Andrew Ramelmeier 2020 $416,000 $50,000 $374,000 $485,221 $203,840 $5,639 $1,534,700
R. Andrew Ramelmeier 2019 $382,965 $ $112,875 $449,453 $153,608 $5,639 $1,104,540
Stéphane Boissel 2020 $318,283 $ $374,000 $485,221 $ $256,472 $1,433,976
Stéphane Boissel 2019 $483,600 $ $158,025 $629,234 $212,784 $1,639 $1,485,282
Stéphane Boissel 2018 $120,390 $100,000 $ $2,052,792 $ $316,884 $2,590,066
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1001233/000162828021006458/sgmo_proxyx2021xdefxvs.htm

Sangamo Therapeutics, Inc Insider Trading

  • The most recent transaction was 17,524 units sold on March 25, 2021 by Gary Loeb worth over $230.04K
  • In the last 18 years, insiders at Sangamo Therapeutics, Inc sold an estimated value of $137.9M and bought an estimated value of $70.08M
  • The most active traders are Edward Lanphier II, Director,  Philip Gregory, SVP Research & CSO,  and Ward Henry Wolff, Exec VP & CFO
  • Insider trading is most common in June, with the busiest year in 2014

SANGAMO THERAPEUTICS, INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1